Abstract
Background Early detection of breast cancer reduces the risk of mortality, with mammography being the gold standard for detecting breast cancer. Currently, there is no consensus on breast screening in transgender patients, with only recommendations from various international health organizations, which differ from one another. The objective of this research was to determine the mammographic projections applicable to transgender patients, in order to propose a mammography protocol and a pre-mammography survey focused on this patient group.
Methodology A semi-structured survey with both closed and open-ended questions was conducted, which was answered by radiologists specializing in mammography. To propose mammographic projections, the survey included questions about the transitional phase, hormone use, surgeries, and breast tissue development. To propose a pre-mammography survey for transgender patients, questions about risk factors and surgical treatments were included.
Conclusions A mammographic protocol is proposed according to the transitional phase, along with a pre-mammography survey for transgender patients, based on information gathered from a survey answered by 20 radiologists specializing in mammography. This contributes significantly to the screening process for this patient group.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
central university of chile scientific ethics committee approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
